Mind Medicine Inc (NAS:MNMD)
$ 8.19 -0.78 (-8.7%) Market Cap: 600.59 Mil Enterprise Value: 438.17 Mil PE Ratio: 0 PB Ratio: 2.93 GF Score: 41/100

Mind Medicine (MindMed) Inc to Host Conference Call Transcript

Dec 14, 2023 / 01:30PM GMT
Release Date Price: $3.6 (+11.46%)
Operator

Fair enough, no, and and good morning, and welcome to the MIND medicine conference call announcing top line preliminary results from the Company's Phase IIb study of MM. one 20 in generalized anxiety disorder.

Currently, all participants are in a listen only mode. This call is being webcast live on the Investors and Media section of mine mix website at Mine met.com and the recording will be available after the call.

For opening remarks, I would like to introduce SEAN Greenway, CFO of mine met. Please go ahead.

Schond Greenway;MindMed;Inc;Chief Financial Officer
Mind Medicine

()-

Hello, and thank you for joining us on today's conference call to discuss top-line results for our Phase IIb study of evident one 20 in patients with generalized anxiety disorder. Our press release describing the results of this study was issued today and is available in the News and Events section in the Investors section of our website. Today's presentation will also be available in the Presentations section in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot